These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

64 related articles for article (PubMed ID: 12530074)

  • 1. Selective protection of non-cancer cells by hypothermia.
    Matijasevic Z
    Anticancer Res; 2002; 22(6A):3267-72. PubMed ID: 12530074
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hypothermia causes a reversible, p53-mediated cell cycle arrest in cultured fibroblasts.
    Matijasevic Z; Snyder JE; Ludlum DB
    Oncol Res; 1998; 10(11-12):605-10. PubMed ID: 10367942
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Low temperature protects mammalian cells from apoptosis initiated by various stimuli in vitro.
    Sakurai T; Itoh K; Liu Y; Higashitsuji H; Sumitomo Y; Sakamaki K; Fujita J
    Exp Cell Res; 2005 Oct; 309(2):264-72. PubMed ID: 16018998
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The topoisomerase II inhibitor, genistein, induces G2/M arrest and apoptosis in human malignant glioma cell lines.
    Schmidt F; Knobbe CB; Frank B; Wolburg H; Weller M
    Oncol Rep; 2008 Apr; 19(4):1061-6. PubMed ID: 18357397
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Apoptosis, cell cycle progression and gene expression in TP53-depleted HCT116 colon cancer cells in response to short-term 5-fluorouracil treatment.
    Adamsen BL; Kravik KL; Clausen OP; De Angelis PM
    Int J Oncol; 2007 Dec; 31(6):1491-500. PubMed ID: 17982676
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Activation of p53 protein in normal and in tumor cells by a novel anticancer agent CHS 828.
    Wojciechowski J; Lövborg H; Wesierska-Gadek J
    Drugs Exp Clin Res; 2003; 29(2):53-67. PubMed ID: 12951835
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The effect of loss of Brca1 on the sensitivity to anticancer agents in p53-deficient cells.
    Fedier A; Steiner RA; Schwarz VA; Lenherr L; Haller U; Fink D
    Int J Oncol; 2003 May; 22(5):1169-73. PubMed ID: 12684687
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Apoptosis in UV-C light irradiated p53 wild-type, apaf-1 and p53 knockout mouse embryonic fibroblasts: interplay of receptor and mitochondrial pathway.
    Tomicic MT; Christmann M; Kaina B
    Apoptosis; 2005 Dec; 10(6):1295-304. PubMed ID: 16215690
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Loss of histone deacetylase 4 causes segregation defects during mitosis of p53-deficient human tumor cells.
    Cadot B; Brunetti M; Coppari S; Fedeli S; de Rinaldis E; Dello Russo C; Gallinari P; De Francesco R; Steinkühler C; Filocamo G
    Cancer Res; 2009 Aug; 69(15):6074-82. PubMed ID: 19622775
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Novel signaling molecules implicated in tumor-associated fatty acid synthase-dependent breast cancer cell proliferation and survival: Role of exogenous dietary fatty acids, p53-p21WAF1/CIP1, ERK1/2 MAPK, p27KIP1, BRCA1, and NF-kappaB.
    Menendez JA; Mehmi I; Atlas E; Colomer R; Lupu R
    Int J Oncol; 2004 Mar; 24(3):591-608. PubMed ID: 14767544
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Enniatin exerts p53-dependent cytostatic and p53-independent cytotoxic activities against human cancer cells.
    Dornetshuber R; Heffeter P; Kamyar MR; Peterbauer T; Berger W; Lemmens-Gruber R
    Chem Res Toxicol; 2007 Mar; 20(3):465-73. PubMed ID: 17326668
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Targeted repression of bone morphogenetic protein 7, a novel target of the p53 family, triggers proliferative defect in p53-deficient breast cancer cells.
    Yan W; Chen X
    Cancer Res; 2007 Oct; 67(19):9117-24. PubMed ID: 17909016
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Repression of SHP-1 expression by p53 leads to trkA tyrosine phosphorylation and suppression of breast cancer cell proliferation.
    Montano X
    Oncogene; 2009 Oct; 28(43):3787-800. PubMed ID: 19749791
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Flavopiridol potentiates the cytotoxic effects of radiation in radioresistant tumor cells in which p53 is mutated or Bcl-2 is overexpressed.
    Hara T; Omura-Minamisawa M; Kang Y; Cheng C; Inoue T
    Int J Radiat Oncol Biol Phys; 2008 Aug; 71(5):1485-95. PubMed ID: 18640498
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evidence for nonautonomous effect of p53 tumor suppressor in carcinogenesis.
    Kiaris H; Chatzistamou I; Trimis G; Frangou-Plemmenou M; Pafiti-Kondi A; Kalofoutis A
    Cancer Res; 2005 Mar; 65(5):1627-30. PubMed ID: 15753354
    [TBL] [Abstract][Full Text] [Related]  

  • 16. P53-independent thermosensitization by mitomycin C in human non-small-cell lung cancer cells.
    Jin ZH; Matsumoto H; Hayashi S; Hatashita M; Ohtsubo T; Shioura H; Kitai R; Kano E
    Int J Radiat Oncol Biol Phys; 2004 Jul; 59(3):852-60. PubMed ID: 15183489
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Induction of apoptosis by pectenotoxin-2 is mediated with the induction of DR4/DR5, Egr-1 and NAG-1, activation of caspases and modulation of the Bcl-2 family in p53-deficient Hep3B hepatocellular carcinoma cells.
    Shin DY; Kim GY; Kim ND; Jung JH; Kim SK; Kang HS; Choi YH
    Oncol Rep; 2008 Feb; 19(2):517-26. PubMed ID: 18202802
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification of PRC1 as the p53 target gene uncovers a novel function of p53 in the regulation of cytokinesis.
    Li C; Lin M; Liu J
    Oncogene; 2004 Dec; 23(58):9336-47. PubMed ID: 15531928
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of hypoxic cell radio-sensitizers in terms of radio-sensitizing and repair-inhibiting potential. Dependency on p53 status of tumor cells and the effects on intratumor quiescent cells.
    Masunaga S; Uto Y; Nagasawa H; Hori H; Nagata K; Suzuki M; Kinashi Y; Ono K
    Anticancer Res; 2006; 26(2A):1261-70. PubMed ID: 16619533
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Differential role of diphenyleneiodonium, a flavoenzyme inhibitor, on p53-dependent and -independent cell cycle progression.
    Song JD; Kim KM; Kim KH; Kim CD; Kim JM; Yoo YH; Park YC
    Int J Oncol; 2008 Dec; 33(6):1299-306. PubMed ID: 19020764
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.